UFP Technologies Inc(UFPT)
USD --+0.00%
Reward63Moderate
Risk34Moderate
📊75%Data
UFPT
+0.0 · +0.00%
USD · NASDAQ
UFP Technologies Inc | Healthcare
Quality Compounder
Market Cap:1.62Bn
ℹ️
Reward Rating
63
Moderate
Top 50% (model universe)
75% data coverage
ℹ️
Risk Rating
34
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on UFPT to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $324.50.

What is UFP Technologies Inc?

designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States.

UFPT · Verdict

Solid reward · moderate risk

UFPT scores well on cash flow and growth with no major weaknesses flagged in the model.

Based on 88% data coverage

UFPT · Verdict

What’s working & what to watch

Strengths 2

  • Cash flow86/100

    13% free-cash-flow margin

  • Growth77/100

    Rev +19.4% CAGR · earnings +17.8%

No major weaknesses flagged.

Model-based scoring. For information only — not financial advice.

What is UFP Technologies Inc?

designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company offers protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 1.62B, and a P/E ratio of 24.5x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (63)

The scoring profile indicates moderate reward potential, with growth and profitability as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap1.62B
P/E Ratio24.486
Dividend YieldN/A
52 Week High274.93
52 Week Low178.26
Last AnnualDecember
IPO Date12/16/1993
IncorporatedUSA
Shares Outstanding8M
No. of Employees4,146
IndustryMedical Devices
ExchangeNASDAQ
Beta1.097
CurrencyUSD